Understanding how chemotherapy affects mobility and falls in cancer patients
Official title: Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer
Funded at Oregon Health & Science University · NIH-10907687 · Data updated 2026-11-12
This study is looking at how chemotherapy affects cancer patients' ability to move around and their chances of falling, so we can better understand which patients might need extra help during treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | September 10, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $597,074 |
| NIH project number | 5R01CA248059-05 |
| Project ID | NIH-10907687 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients who are being treated with neurotoxic chemotherapy.
✕Less likely to help
Patients who are not undergoing neurotoxic chemotherapy or those with conditions unrelated to cancer treatment may not benefit from this research.
What this research studies
This research investigates the impact of neurotoxic chemotherapy on cancer patients, particularly focusing on how it affects their mobility and increases the risk of falls. By tracking symptoms, mobility, and falls before, during, and after treatment, the study aims to identify which patients are most at risk and what specific mobility issues contribute to falls. The approach includes detailed symptom tracking, clinical tests, and continuous monitoring of daily activities. The goal is to provide insights that can help clinicians and rehabilitation providers improve care for patients undergoing chemotherapy.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies for falls and functional decline in cancer patients undergoing chemotherapy.
How similar studies have gone: Other research has indicated that understanding mobility issues in cancer patients can lead to improved outcomes, suggesting that this approach has potential for success.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Winters-Stone, Kerri M — Oregon Health & Science University
- Study coordinator: Winters-Stone, Kerri M
Related research
Other NIH-funded projects on the same topics.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Dual targeting of heart cell receptors to prevent chemotherapy heart damage
Atrial patients receiving the chemotherapy drug doxorubicin may be protected from heart damage by targeting two heart cell receptors at once.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
-
Genetic clues for doxorubicin heart risk using patient-derived heart cells
A research project tests how human heart cells grown from stem cells react to a common chemotherapy to see which genetic differences may raise the risk of heart damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.